Skip to main content
Clinical Trials/NCT06309433
NCT06309433
Recruiting
Not Applicable

Assessment of Bone Mineral Density at the Interface With the Femoral and Tibial Components in Patients Undergoing Total Knee Prosthesis of Different Design and Material

Istituto Ortopedico Rizzoli2 sites in 1 country50 target enrollmentAugust 30, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periprosthetic Osteolysis
Sponsor
Istituto Ortopedico Rizzoli
Enrollment
50
Locations
2
Primary Endpoint
Periprosthetic bone mineral density measurement
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

compare changes in BMD via DXA at the level of the femoral and tibial periprosthetic bone between two groups of patients undergoing cemented TKA of different design (posterior stabilization vs posterior cruciate preservation) with proms at a 2-year follow-up.

Registry
clinicaltrials.gov
Start Date
August 30, 2023
End Date
April 1, 2028
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stefano Zaffagnini

professor

Istituto Ortopedico Rizzoli

Eligibility Criteria

Inclusion Criteria

  • Patients aged ≥ 45 years
  • Patients who are candidates for primary cemented total knee replacement based on physical examination and medical history, including diagnosis of severe knee pain and disability due to at least one of the following:
  • to. Primary or secondary osteoarthritis b. Collagen disorders and/or avascular necrosis of the femoral condyle c. Moderate valgus, varus or flexion deformities (HKA within ±10°, flexion contracture \<10°)
  • Patients consenting and able to complete planned study procedures and follow-up assessments
  • Patients informed about the nature of the study who signed the "informed consent" approved by the ethics committee.

Exclusion Criteria

  • Patients aged \< 45 years;
  • Patients who have already undergone hip or knee arthroplasty ankle, previous osteotomy, with severe axial deformities or suffering from rheumatoid arthritis, diabetes or neuromuscular diseases. In this way, homogeneity of the investigated cohort will be guaranteed;
  • Pregnant women. -

Outcomes

Primary Outcomes

Periprosthetic bone mineral density measurement

Time Frame: 24 months

measurement of periprosthetic bone mineral density using dual-energy x-ray absorptiometry

Periprosthetic bone mineral density measurement

Time Frame: at baseline (day 0)

measurement of periprosthetic bone mineral density using dual-energy x-ray absorptiometry

Periprosthetic bone mineral density measurement

Time Frame: 6 months

measurement of periprosthetic bone mineral density using dual-energy x-ray absorptiometry

Periprosthetic bone mineral density measurement

Time Frame: 12 months

measurement of periprosthetic bone mineral density using dual-energy x-ray absorptiometry

Secondary Outcomes

  • Western Ontario and McMaster Universities Arthritis Index(24 months)
  • Knee Society Score(24 months)
  • Knee injury and Osteoarthritis Outcome Score(24 months)
  • 36-Item Short Form Health Survey(24 months)
  • Knee Society Score(at baseline (day 0))
  • Knee Society Score(6 months)
  • Knee Society Score(12 months)
  • Western Ontario and McMaster Universities Arthritis Index(at baseline (day 0))
  • Western Ontario and McMaster Universities Arthritis Index(6 months)
  • Western Ontario and McMaster Universities Arthritis Index(12 months)
  • Knee injury and Osteoarthritis Outcome Score(at baseline, (day 0))
  • Knee injury and Osteoarthritis Outcome Score(6 months)
  • Knee injury and Osteoarthritis Outcome Score(12 months)
  • 36-Item Short Form Health Survey(at baseline (day 0))
  • 36-Item Short Form Health Survey(6 months)
  • 36-Item Short Form Health Survey(12 months)

Study Sites (2)

Loading locations...

Similar Trials